- Report
- June 2021
Global
From €7250EUR$7,500USD£6,232GBP
- Report
- September 2020
- 125 Pages
Europe
From €5795EUR$5,995USD£4,981GBP
- Report
- September 2020
- 86 Pages
North America
From €5795EUR$5,995USD£4,981GBP
- Report
- September 2020
- 121 Pages
Asia Pacific
From €5795EUR$5,995USD£4,981GBP
- Report
- September 2020
- 106 Pages
Brazil, China, India, ... Brazil, China, India, Russia
From €5795EUR$5,995USD£4,981GBP
- Report
- April 2019
Global
From €7250EUR$7,500USD£6,232GBP
- Report
- February 2024
- 93 Pages
Global
From €3500EUR$3,878USD£3,114GBP
- Report
- February 2024
- 185 Pages
Global
From €3480EUR$3,600USD£2,991GBP
- Report
- September 2023
- 160 Pages
Global
From €2899EUR$2,999USD£2,492GBP
The Endometrial Ablation Device market is a segment of the larger Surgical Devices market. Endometrial ablation devices are used to treat heavy menstrual bleeding, a condition that affects millions of women worldwide. These devices are minimally invasive and can be used to destroy the endometrial lining of the uterus, reducing or eliminating menstrual bleeding. Endometrial ablation devices come in a variety of forms, including thermal, hydrothermal, and microwave ablation.
The Endometrial Ablation Device market is expected to grow in the coming years due to the increasing prevalence of heavy menstrual bleeding and the growing demand for minimally invasive treatments. Additionally, technological advancements in the field are expected to drive market growth.
Some of the major companies in the Endometrial Ablation Device market include Hologic, Inc., Medtronic, Boston Scientific Corporation, Johnson & Johnson, and Olympus Corporation. Show Less Read more